Sponsor
Ubix Therapeutics Inc.
7/1401 Beobwonro11-Gil, 05836
About the sponsor
Ubix Therapeutics Inc. is active in B-cell malignancies, with clinical research centered on cancers arising from B-lymphocytes and related hematologic disease states.
- Relapsed cancer
- Refractory hematologic malignancy
- Blood cancer
The sponsor’s current research interest is focused on treatment-resistant hematologic oncology within a network of collaborating sites in South Korea.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.